Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye
- 30 September 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (10) , 1803-1808
- https://doi.org/10.1016/0959-8049(96)00197-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Retinoids: in vitro interaction with retinol‐binding protein and influence on plasma retinolThe FASEB Journal, 1993
- Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer.Journal of Clinical Oncology, 1993
- In vitro interaction of fenretinide with plasma retinol‐binding protein and its functional consequencesFEBS Letters, 1992
- Long-term tolerability of fenretinide (4-HPR) in breast cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- Phase II study of Fenretinide (N-[4-Hydroxyphenyl]retinamide) in advanced breast cancer and melanomaInvestigational New Drugs, 1990
- Tolerability of the synthetic retinoid fenretinide® (HPR)European Journal of Cancer and Clinical Oncology, 1989
- Comparative Aspects of Carotenoids and Retinoids as Chemopreventive Agents for CancerJournal of Nutrition, 1989
- Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasisClinical and Experimental Dermatology, 1986
- Abnormal Retinal Function Associated With Fenretinide, a Synthetic RetinoidArchives of Ophthalmology (1950), 1986
- Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl)-retinamideCarcinogenesis: Integrative Cancer Research, 1983